Filing Details
- Accession Number:
- 0001140361-16-046282
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-04 17:27:12
- Reporting Period:
- 2015-12-31
- Filing Date:
- 2016-01-04
- Accepted Time:
- 2016-01-04 17:27:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1416792 | Relypsa Inc | RLYP | Pharmaceutical Preparations (2834) | 260893742 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591468 | Wilhelm Stahl | C/O Relypsa, Inc. 100 Cardinal Way Redwood City CA 94063 | Svp, Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-31 | 16,291 | $3.96 | 31,144 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-31 | 3,709 | $3.96 | 34,853 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-31 | 20,000 | $28.53 | 14,853 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-12-31 | 16,291 | $0.00 | 16,291 | $3.96 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-12-31 | 3,709 | $0.00 | 3,709 | $3.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,759 | 2021-09-13 | No | 4 | M | Direct | |
| 46,597 | 2022-09-27 | No | 4 | M | Direct |
Footnotes
- Includes 14,000 Restricted Stock Units.
- The sale reported in this Form 4 was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades in prices ranging from $28.19 to $28.9515, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- 100% of the shares subject to the option are fully vested and exercisable.
- The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from September 19, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Billionaire Hedge Funds
